AKT1 and neoplasm: Matter and colleagues did not find an increase in overall tumor burden using AKT-NRasG12V models combined with 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) [27], although no study to date has combined SB/AKT/c-Met with injury.